InsidersTradesSigma
Browse the detailed record of transactions filed by OSBORNE DAVID W, Cadre supérieur. Officer active across 1 company, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 3 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €54k. History available since 1 March 2022. The latest transaction was disclosed on 21 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
David W. Osborne is Chief Technical Officer at Arcutis Biotherapeutics, Inc. He is responsible for leading technical initiatives and innovation within the company. His role is essential in ensuring that Arcutis remains at the forefront of technological advancements.